RIPK1 anticorps (Middle Region)
-
- Antigène Voir toutes RIPK1 Anticorps
- RIPK1 (Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))
-
Épitope
- Middle Region
-
Reactivité
- Humain, Boeuf (Vache)
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp RIPK1 est non-conjugé
-
Application
- Western Blotting (WB)
- Réactivité croisée
- Boeuf (Vache)
- Purification
- Purified
- Immunogène
- RIPK1 antibody was raised in rabbit using the middle region of RIPK1 as the immunogen
- Top Product
- Discover our top product RIPK1 Anticorps primaire
-
-
- Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
RIPK1 Blocking Peptide, catalog no. 33R-8158, is also available for use as a blocking control in assays to test for specificity of this RIPK1 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Antigène
- RIPK1 (Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))
- Autre désignation
- RIPK1 (RIPK1 Produits)
- Synonymes
- anticorps RIP, anticorps RIP1, anticorps D330015H01Rik, anticorps Rinp, anticorps Rip1, anticorps rip1, anticorps ripk1, anticorps xRIP1beta, anticorps xrip1, anticorps receptor interacting serine/threonine kinase 1, anticorps receptor (TNFRSF)-interacting serine-threonine kinase 1, anticorps receptor interacting serine/threonine kinase 1 L homeolog, anticorps RIPK1, anticorps Ripk1, anticorps ripk1.L
- Sujet
- FAK overexpression in human tumors provides a survival signal function by binding to RIP and inhibiting its interaction with the death receptor complex. Synonyms: Polyclonal RIPK1 antibody, Anti-RIPK1 antibody, receptor, TNFRSF-interacting serine-threonine kinase 1 antibody.
- Pathways
- Signalisation NF-kappaB, Apoptose, Caspase Cascade in Apoptosis, Signalisation TLR, Activation of Innate immune Response, Inositol Metabolic Process, Positive Regulation of Endopeptidase Activity, Hepatitis C, Protein targeting to Nucleus, Toll-Like Receptors Cascades, Negative Regulation of intrinsic apoptotic Signaling, SARS-CoV-2 Protein Interactome, Ubiquitin Proteasome Pathway
-